Cargando…
Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
With the in-depth research and wide application of immunotherapy recently, new therapies based on oncolytic viruses are expected to create new prospects for cancer treatment via eliminating the suppression of the immune system by tumors. Currently, an increasing number of viruses are developed and e...
Autores principales: | Tang, Chao, Li, Lan, Mo, Tong, Na, Jintong, Qian, Zhangbo, Fan, Dianfa, Sun, Xinjun, Yao, Min, Pan, Lina, Huang, Yong, Zhong, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131313/ https://www.ncbi.nlm.nih.gov/pubmed/35612653 http://dx.doi.org/10.1007/s12094-022-02830-x |
Ejemplares similares
-
Study of Oncolytic Virus Preservation and Formulation
por: Pan, Lina, et al.
Publicado: (2023) -
Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023) -
Aptamer‐based biosensors and application in tumor theranostics
por: Mo, Tong, et al.
Publicado: (2021) -
Signal Amplification-Based Biosensors and Application in RNA Tumor Markers
por: Li, Haiping, et al.
Publicado: (2023) -
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
por: Shen, Zhen, et al.
Publicado: (2023)